Age-Based Testing Misses Most With Inherited Cancer Risk Frederik Joelving

https://www.medscape.com/viewarticle/age-based-testing-misses-most-inherited-cancer-risk-2026a10012ct?src= Restricting germline genetic testing to patients diagnosed with cancer before age 50 may miss the large majority of all those with inherited pathogenic variants, a new study suggested.